Gene · 54567
Papers4,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 4,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exosomes for angiogenesis induction in ischemic disorders. | J Cell Mol Med | 2023 | 36786037 | PubTator, text mining | PubMed |
| Effects of immune system cells in GvHD and corresponding therapeutic strategies. | Blood Res | 2023 | 36774947 | PubTator, text mining | PubMed |
| A Review of Plant Selenium-Enriched Proteins/Peptides: Extraction, Detection, Bioavailability, and Effects of Processing. | Molecules | 2023 | 36770890 | PubTator, text mining | PubMed |
| The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment. | Int J Mol Sci | 2023 | 36769332 | PubTator, text mining | PubMed |
| Understanding the Roles of the Hedgehog Signaling Pathway during T-Cell Lymphopoiesis and in T-Cell Acute Lymphoblastic Leukemia (T-ALL). | Int J Mol Sci | 2023 | 36769284 | PubTator, text mining | PubMed |
| Re-Sensitizing Cancer Stem Cells to Conventional Chemotherapy Agents. | Int J Mol Sci | 2023 | 36768445 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cells and Their Exocytotic Vesicles. | Int J Mol Sci | 2023 | 36768406 | PubTator, text mining | PubMed |
| Molecular Determinants of Chronic Venous Disease: A Comprehensive Review. | Int J Mol Sci | 2023 | 36768250 | PubTator, text mining | PubMed |
| An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis. | Cancers (Basel) | 2023 | 36765694 | PubTator, text mining | PubMed |
| The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies. | Cancer Cell Int | 2023 | 36765409 | PubTator, text mining | PubMed |
| Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors. | Cell Death Dis | 2023 | 36765032 | PubTator, text mining | PubMed |
| Hypoxia induced lactate acidosis modulates tumor microenvironment and lipid reprogramming to sustain the cancer cell survival. | Front Oncol | 2023 | 36761981 | PubTator, text mining | PubMed |
| Krüppel-like factors in tumors: Key regulators and therapeutic avenues. | Front Oncol | 2023 | 36761967 | PubTator, text mining | PubMed |
| BASP1 promotes high glucose-induced endothelial apoptosis in diabetes via activation of EGFR signaling. | J Diabetes Investig | 2023 | 36756695 | PubTator, text mining | PubMed |
| In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression. | Cell Oncol (Dordr) | 2023 | 36745330 | PubTator, text mining | PubMed |
| Expressions and Prognostic Values of Notch3 and DLL4 in Human Breast Cancer. | Technol Cancer Res Treat | 2023 | 36740988 | PubTator, text mining | PubMed |
| FYN: emerging biological roles and potential therapeutic targets in cancer. | J Transl Med | 2023 | 36740671 | PubTator, text mining | PubMed |
| Integrin-Dependent Cell-Matrix Adhesion in Endothelial Health and Disease. | Circ Res | 2023 | 36730379 | PubTator, text mining | PubMed |
Single-Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus-Associated (HPVA) and Non-HPVA Adenocarcinoma. | Adv Sci (Weinh) | 2023 | 36725337 | PubTator, text mining | PubMed |
| Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer. | J Exp Clin Cancer Res | 2023 | 36717865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54567/papers?page=32